ANA LIMON CARRERA

Autre

OtherF

ES·CNMV

ORYZON GENOMICS, S.A.Oryzon Genomics, S.A.Oryzon Genomics SA ORYZON GENOMICS SA

0

Total declarations

0

Companies

—

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

Explore the detailed record of transactions filed by ANA LIMON CARRERA, Autre. Director active across 4 companies, notably ORYZON GENOMICS, S.A.. Cumulatively, 2 filings have been recorded. The latest transaction was filed on 6 February 2024 — Other. Regulator: CNMV. All data is free.

Declarations2 total

Executives●OtherOOryzon Genomics SA35CNMV

A

ANA LIMON CARRERAVICEPRESIDENTE SENIOR DE DESARROLLO CLINICO Y ASUNTOS MEDICOS GLOBALES

€10,90010,000 shares@ €1.090.0047% mcap100.0% of flow

ShareXOOF

CNMV:2024020827·6 Feb 2024

CNMV ↗

Executives●OtherOOryzon Genomics, S.A.36CNMV

A

ANA LIMON CARRERAVICEPRESIDENTE SENIOR DE DESARROLLO CLINICO Y ASUNTOS MEDICOS GLOBALES

€24,80010,000 shares@ €2.480.011% mcap100.0% of flow

ShareXOOF

CNMV:2023021941·6 Feb 2023

CNMV ↗

2 of 2 declarations

About ANA LIMON CARRERA

Ana Limon Carrera is the Senior Vice President of Clinical Development and Global Medical Affairs at Oryzon Genomics, S.A. She is responsible for clinical development strategy and medical affairs, contributing to innovation in the biopharmaceutical sector.